Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

February 01, 2005; Volume 33,Issue 2

Short Communications

  • You have access
    CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES
    Nirmala Raghavan, Donglu Zhang, Mingshe Zhu, Jianing Zeng and Lisa Christopher
    Drug Metabolism and Disposition February 2005, 33 (2) 203-208; DOI: https://doi.org/10.1124/dmd.104.001198
  • You have access
    LANSOPRAZOLE ENANTIOMER ACTIVATES HUMAN LIVER MICROSOMAL CYP2C9 CATALYTIC ACTIVITY IN A STEREOSPECIFIC AND SUBSTRATE-SPECIFIC MANNER
    Kwang-Hyeon Liu, Min-Jung Kim, Woo Moon Jung, Wonku Kang, In-June Cha and Jae-Gook Shin
    Drug Metabolism and Disposition February 2005, 33 (2) 209-213; DOI: https://doi.org/10.1124/dmd.104.001438
  • You have access
    EXTRAHEPATIC METABOLISM OF CARBAMATE AND ORGANOPHOSPHATE THIOETHER COMPOUNDS BY THE FLAVIN-CONTAINING MONOOXYGENASE AND CYTOCHROME P450 SYSTEMS
    Bjarte Furnes and Daniel Schlenk
    Drug Metabolism and Disposition February 2005, 33 (2) 214-218; DOI: https://doi.org/10.1124/dmd.104.000984

Articles

  • You have access
    MAPPING OF MULTIDRUG RESISTANCE GENE 1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN ISOFORM 1 TO 5 mRNA EXPRESSION ALONG THE HUMAN INTESTINAL TRACT
    Christian Zimmermann, Heike Gutmann, Petr Hruz, Jean-Pierre Gutzwiller, Christoph Beglinger and Juergen Drewe
    Drug Metabolism and Disposition February 2005, 33 (2) 219-224; DOI: https://doi.org/10.1124/dmd.104.001354
  • You have access
    FUNCTIONAL ANALYSIS OF DOG MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) IN COMPARISON WITH RAT MRP2
    Mizuki Ninomiya, Kousei Ito and Toshiharu Horie
    Drug Metabolism and Disposition February 2005, 33 (2) 225-232; DOI: https://doi.org/10.1124/dmd.104.002196
  • You have access
    IMPACT OF TRANSCRIPTION FACTOR PROFILE AND CHROMATIN CONFORMATION ON HUMAN HEPATOCYTE CYP3A GENE EXPRESSION
    Anna Phillips, Steve R. Hood, G. Gordon Gibson and Nick J. Plant
    Drug Metabolism and Disposition February 2005, 33 (2) 233-242; DOI: https://doi.org/10.1124/dmd.104.001461
  • You have access
    BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONE-IMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4
    Amit S. Kalgutkar, Alfin D. N. Vaz, Mary E. Lame, Kirk R. Henne, John Soglia, Sabrina X. Zhao, Yuri A. Abramov, Franco Lombardo, Claire Collin, Zachary S. Hendsch and Cornelis E. C. A. Hop
    Drug Metabolism and Disposition February 2005, 33 (2) 243-253; DOI: https://doi.org/10.1124/dmd.104.001735
  • You have access
    FUNCTIONAL SIGNIFICANCE OF A NATURAL ALLELIC VARIANT OF HUMAN CARBONYL REDUCTASE 3 (CBR3)
    Sukhwinder S. Lakhman, Debashis Ghosh and Javier G. Blanco
    Drug Metabolism and Disposition February 2005, 33 (2) 254-257; DOI: https://doi.org/10.1124/dmd.104.002006
  • You have access
    METABOLISM OF NICOTINE AND COTININE BY HUMAN CYTOCHROME P450 2A13
    Ziping Bao, Xiao-Yang He, Xinxin Ding, Saileta Prabhu and Jun-Yan Hong
    Drug Metabolism and Disposition February 2005, 33 (2) 258-261; DOI: https://doi.org/10.1124/dmd.104.002105
  • You have access
    SERTRALINE IS METABOLIZED BY MULTIPLE CYTOCHROME P450 ENZYMES, MONOAMINE OXIDASES, AND GLUCURONYL TRANSFERASES IN HUMAN: AN IN VITRO STUDY
    R. Scott Obach, Loretta M. Cox and Larry M. Tremaine
    Drug Metabolism and Disposition February 2005, 33 (2) 262-270; DOI: https://doi.org/10.1124/dmd.104.002428
  • You have access
    FORMATION AND PROTEIN BINDING OF THE ACYL GLUCURONIDE OF A LEUKOTRIENE B4 ANTAGONIST (SB-209247): RELATION TO SPECIES DIFFERENCES IN HEPATOTOXICITY
    Jane R. Kenny, James L. Maggs, Justice N. A. Tettey, Andrew W. Harrell, Steven G. Parker, Stephen E. Clarke and B. Kevin Park
    Drug Metabolism and Disposition February 2005, 33 (2) 271-281; DOI: https://doi.org/10.1124/dmd.104.001677
  • You have access
    ABSORPTION AND ELIMINATION OF FORMATE FOLLOWING ORAL ADMINISTRATION OF CALCIUM FORMATE IN FEMALE HUMAN SUBJECTS
    Robert P. Hanzlik, Stephen C. Fowler and Janis T. Eells
    Drug Metabolism and Disposition February 2005, 33 (2) 282-286; DOI: https://doi.org/10.1124/dmd.104.001289
  • You have access
    MULTIPLE TRANSPORT SYSTEMS MEDIATE THE HEPATIC UPTAKE AND BILIARY EXCRETION OF THE METABOLICALLY STABLE OPIOID PEPTIDE [d-PENICILLAMINE2,5]ENKEPHALIN
    Keith A. Hoffmaster, Maciej J. Zamek-Gliszczynski, Gary M. Pollack and Kim L. R. Brouwer
    Drug Metabolism and Disposition February 2005, 33 (2) 287-293; DOI: https://doi.org/10.1124/dmd.104.001420
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 33 (2)
Drug Metabolism and Disposition
Vol. 33, Issue 2
1 Feb 2005
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics